Evaluation of Acromegaly by Radioimmunoassay of Somatomedin-C
David R. Clemmons(University of North Carolina at Chapel Hill), L E Underwood, Judson J. Van Wyk(Michigan State University), Bernard Kliman, Raymond N. Kjellberg, E. Chester Ridgway(University of Colorado Denver)
Cited by 367
Related Papers
The Colorado Thyroid Disease Prevalence Study
|Archives of Internal Medicine|2000|2.8k
Treatment of Acromegaly with the Growth Hormone–Receptor Antagonist Pegvisomant
|New England Journal of Medicine|2000|874
Guidelines for Acromegaly Management: An Update
|The Journal of Clinical Endocrinology & Metabolism|2009|763
Long-term treatment of acromegaly with pegvisomant, a growth hormone receptor antagonist
|The Lancet|2001|643
A Comparison of Recombinant Human Thyrotropin and Thyroid Hormone Withdrawal for the Detection of Thyroid Remnant or Cancer1
|The Journal of Clinical Endocrinology & Metabolism|1999|564